ImmuCell reports mixed Q4 2025 results, pauses Re-Tain development
Go back to ImmuCell reports mixed Q4 2025 results, pauses Re-Tain development| Immucell Corp (NASDAQ: ICCC) | Delayed: 11.04 -0.17 (1.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.21 | 52 Week High | $8.29 | |||
| Open | $11.33 | 52 Week Low | $4.99 | |||
| Day High | $11.33 | P/E | 138.00 | |||
| Day Low | $10.99 | EPS | $0.08 | |||
| Volume | 16,442 | |||||

